Biotech Series B Investors & VC Firms
724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.
Arkin Digital Health
Seed–Late Stage
1 person
P5 Health Ventures
WestportSeed–Series B
1 person
Colt Ventures
DallasSeed–Growth$15M
3 people
Robust
San FranciscoPre-Seed–Series B$1M – $2M
1 person
Hanne Capital
ShanghaiSeed–Growth
2 people
Hatch BioFund
DoylestownPre-Seed–Late Stage
3 people
PRIVEQ Capital Funds
TorontoSeed–Growth
3 people
Extens
ParisSeries A–Series B$3.2M – $16.2M
2 people
HealthCare Ventures, LLC
CambridgeSeries A–Late Stage$1M – $20M
1 person
JourneyOne Ventures
BoulderPre-Seed–Growth
1 person
Cathay Health
San FranciscoSeed–Late Stage
3 people
Realist Ventures
DarienSeed–Late Stage$25K – $500K
1 person
Majuven
SingaporeSeed–Growth
4 people
Heron Capital
IndianapolisSeries A–Series B$10M
3 people
Milano Investment Partners SGR
MilanSeed–Late Stage
10 people
Linearis Ventures
Quebec CitySeed–Series B
3 people
Aurum Ventures MKI
Ramat GanSeed–Late Stage
8 people
Nimble Ventures
San FranciscoSeed–Series B
1 person
Bas1s Ventures
Series A–Late Stage
Hotung Investment Holdings Ltd.
SingaporeSeries A–Late Stage$300K – $1.5M
Stone Bridge Ventures
SeoulSeed–Late Stage
MB Venture Partners
MemphisPre-Seed–Growth
2 people
Sustainable Conversion Ventures
Sun LakesSeries B–Late Stage
2 people
Investissement Quebec
QuébecSeed–Growth
1 person
Related lists
Series B Investors & VC Firms (2951)Biotech Investors & VC Firms (2483)Biotech Seed Investors & VC Firms (2027)Series B Investors & VC Firms in North America (1738)Biotech Series A Investors & VC Firms (1627)Biotech Investors & VC Firms in North America (1601)Series B Investors & VC Firms in United States (1573)Biotech Investors & VC Firms in United States (1450)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Europe (1073)
Data sourced from public filings and firms' own websites — see our methodology.































